MedPath
HSA Approval

NOVOFEN 20 TABLET 20 mg

SIN06409P

NOVOFEN 20 TABLET 20 mg

NOVOFEN 20 TABLET 20 mg

July 4, 1991

GOLDPLUS UNIVERSAL PTE LTD

GOLDPLUS UNIVERSAL PTE LTD

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantGOLDPLUS UNIVERSAL PTE LTD
Licence HolderGOLDPLUS UNIVERSAL PTE LTD

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

TABLET

ORAL

Medical Information

L02BA01

tamoxifen

Manufacturer Information

GOLDPLUS UNIVERSAL PTE LTD

REMEDICA LTD

Active Ingredients

TAMOXIFEN CITRATE EQV TAMOXIFEN

20 mg

Tamoxifen

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

NOVOFEN 20 TABLET 20 mg - HSA Approval | MedPath